What companies are NBIX's competitors?

Neurocrine Biosciences, Inc. (NBIX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does NBIX compare to its peers?

The peer comparison table on this page shows Neurocrine Biosciences, Inc. (NBIX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does NBIX operate in?

Neurocrine Biosciences, Inc. (NBIX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

NBIX

Neurocrine Biosciences, Inc.

NASDAQ·Biotechnology · Healthcare

$142.70$0.59−0.41%

Market cap$14.51B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About NBIX

What companies are NBIX's competitors?: Neurocrine Biosciences, Inc. (NBIX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does NBIX compare to its peers?: The peer comparison table on this page shows Neurocrine Biosciences, Inc. (NBIX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does NBIX operate in?: Neurocrine Biosciences, Inc. (NBIX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

NBIX

Neurocrine Biosciences, Inc.

NASDAQ·Biotechnology · Healthcare

$142.70$0.59−0.41%

Market cap$14.51B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


JAZZJAZZJazz Pharmaceuticals plc	Jazz Pharmaceuticals plc	$214.00	$13.9B
AXSMAXSMAxsome Therapeutics, Inc.	Axsome Therapeutics, Inc.	$145.04	$7.6B
HLBBFHLBBFH. Lundbeck A/S	H. Lundbeck A/S	$7.10	$5.6B
ACADACADAcadia Pharmaceuticals Inc.	Acadia Pharmaceuticals Inc.	$19.73	$3.4B
SUPNSUPNSupernus Pharmaceuticals, Inc.	Supernus Pharmaceuticals, Inc.	$40.70	$2.4B
BHVNBHVNBiohaven Ltd.	Biohaven Ltd.	$13.88	$2.1B
RAPPRAPPRapport Therapeutics, Inc. Common Stock	Rapport Therapeutics, Inc. Common Stock	$25.93	$1.2B
GHRSGHRSGH Research PLC	GH Research PLC	$18.07	$1.2B
VNDAVNDAVanda Pharmaceuticals Inc.	Vanda Pharmaceuticals Inc.	$4.01	$242.5M
NMRANMRANeumora Therapeutics, Inc. Common Stock	Neumora Therapeutics, Inc. Common Stock	$0.38	$71.3M

Frequently Asked Questions About NBIX

What companies are NBIX's competitors?: Neurocrine Biosciences, Inc. (NBIX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does NBIX compare to its peers?: The peer comparison table on this page shows Neurocrine Biosciences, Inc. (NBIX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does NBIX operate in?: Neurocrine Biosciences, Inc. (NBIX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.